Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03143829 · ClinicalTrials.gov registry record · NA
Promoting Cancer Symptom Management in Older Adults
A NA study, sponsored by University of Central Florida.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT03143829 is a NA study that has completed, run by University of Central Florida. The registered enrollment target is 80 participants.
The verdict
NCT03143829, a NA study, has completed, sponsored by University of Central Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of the project is to estimate the effect size of a technology based intervention for older adults with cancer for nausea and vomiting. Participants will be randomized to either an intervention or a wait control group. Outcomes such as symptom severity, quality of life and resource use will be examined.
Interventions
- OTHER eSSET-CINV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2016-08-11 |
| Est. Completion | 2018-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03143829
The ClinicalTrials.gov registry entry for NCT03143829 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Central Florida, which has 91 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which eSSET-CINV is the first listed.
NCT03143829 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03143829 about?
NCT03143829 is a clinical study titled "Promoting Cancer Symptom Management in Older Adults". The purpose of the project is to estimate the effect size of a technology based intervention for older adults with cancer for nausea and vomiting. Participants will be randomized to either an intervention or a wait control group. Outcomes such as symptom severity, quality of life and resource use wi...
What is the current status of trial NCT03143829?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2016-08-11. Estimated completion is 2018-08-31.
What interventions are being tested in trial NCT03143829?
The interventions under investigation include: eSSET-CINV (OTHER).
Who is sponsoring clinical trial NCT03143829?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.